AIC
VSTM icon

Ameritas Investment Company’s Verastem VSTM Stock Holding History

Ameritas Investment Company’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-417
Closed -$17K – 1767
2018
Q4 		$17K Buy
+417
New +$25.5K ﹤0.01% 926

Other funds holding VSTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Company's VSTM Position: Q1 2019 in Review

Ameritas Investment Company sold out of Verastem (VSTM) in Q1 2019, closing a stake of 417 shares — an estimated $17K sold.

Ameritas Investment Company first reported a position in VSTM in Q4 2018 and held it in 1 quarter. The position peaked at $17K in Q4 2018. 112 funds tracked by Wall St. Rank hold VSTM as of Q1 2019.

  • Ameritas Investment Company reported no remaining Verastem position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 417 Verastem shares in Q1 2019, an estimated $17K.
  • Ameritas Investment Company first reported a position in Verastem in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's Verastem position peaked at $17K in Q4 2018.
  • 112 funds tracked by Wall St. Rank held Verastem as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.